Orrin Hatch: “If the FDA is updating its thinking in its regulatory capacity, I would think that finalizing guidance provides more…”

Understanding what is happening in field and regional offices is critical in the role of executive leader of the agency.

I urge Congress pass the OPEN ACT before the end of this year.

This is a long-overdue nomination.

I stand by everything I said during my questioning of Mr. Saul, including concerns about budget summary data.